Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2006112685) NEUROTHERAPEUTIC AZOLE COMPOUNDS
Latest bibliographic data on file with the International Bureau   
Pub. No.: WO/2006/112685 International Application No.: PCT/KR2006/001523
Publication Date: 26.10.2006 International Filing Date: 21.04.2006
IPC:
C07D 257/04 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
257
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
02
not condensed with other rings
04
Five-membered rings
Applicants:
CHOI, Yong-Moon [US/US]; US (UsOnly)
KIM, Choon-Gil [KR/KR]; KR (UsOnly)
KANG, Young-Sun [KR/KR]; KR (UsOnly)
YI, Han-Ju [KR/KR]; KR (UsOnly)
LEE, Hyun-Seok [KR/KR]; KR (UsOnly)
KU, Bon-Chul [KR/KR]; KR (UsOnly)
LEE, Eun-Ho [KR/KR]; KR (UsOnly)
IM, Dae-Joong [KR/KR]; KR (UsOnly)
SHIN, Yu-Jin [KR/KR]; KR (UsOnly)
SK HOLDINGS CO., LTD. [KR/KR]; 99 Seorin-dong Jongro-ku Seoul 110-110, KR (AllExceptUS)
Inventors:
CHOI, Yong-Moon; US
KIM, Choon-Gil; KR
KANG, Young-Sun; KR
YI, Han-Ju; KR
LEE, Hyun-Seok; KR
KU, Bon-Chul; KR
LEE, Eun-Ho; KR
IM, Dae-Joong; KR
SHIN, Yu-Jin; KR
Agent:
C & S LOGOS PATENT AND LAW OFFICE; 13th Floor, Seocho-Pyunghwa Building 1451-34 Seocho-dong Seocho-gu Seoul 137-070, KR
Priority Data:
60/674,53022.04.2005US
Title (EN) NEUROTHERAPEUTIC AZOLE COMPOUNDS
(FR) COMPOSES AZOLE NEUROTHERAPEUTIQUES
Abstract:
(EN) Azole compounds containing carbamoyl group and pharmaceutically useful salts thereof are described. The compounds are effective anticonvulsants which are used in the treatment of disorders of the central nervous system, especially as anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm.
(FR) Composés azole contenant un groupe carbamoyle et sels pharmaceutiquement utiles correspondants, efficaces comme anticonvulsifs dans le traitement des troubles du système nerveux central, en particulier l'anxiété, la dépression, les convulsions, l'épilepsie, la migraine, les troubles bipolaires, l'abus de drogues, l'abus du tabac, le trouble d'hyperactivité avec déficit de l'attention, l'obésité, les troubles du sommeil, la douleur neuropathique, la déficience cognitive, la neurodégénérescence, l'accident vasculaire cérébral et les spasmes musculaires.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)